The prevalence and predictive factors of dentine hypersensitivity among adults in Turkey.


Journal

BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684

Informations de publication

Date de publication:
11 07 2023
Historique:
received: 02 04 2023
accepted: 15 06 2023
medline: 13 7 2023
pubmed: 12 7 2023
entrez: 11 7 2023
Statut: epublish

Résumé

This study sought to determine the prevalence of dentine hypersensitivity (DH) among adults in Turkey. Also, to ascertain the association between DH and both etiological predictors and demographic patient characteristics. Using a questionnaire and thermal and evaporative tests, 259 women and 209 men in the age range of 18 to 72 were analyzed. Individually, a clinical evaluation of DH signs was conducted. The DMFT index, gingival index, and gingival bleeding were reported for each subject. The gingival recession and tooth wear of sensitive teeth were also evaluated. Pearson Chi-square test was used to compare categorical data. Logistic Regression Analysis was used to examine the risk factors of DH. Data with dependent categorical variables were compared using the McNemar-Browker test. The significance level was p < 0.05. The average age of the population was 35.6 years. In the present study, a total of 12,048 teeth were analyzed. 1755 had thermal hypersensitivity (14.57%), while 470 experienced evaporative hypersensitivity (3.9%). The incisors were the teeth most impacted by DH, whereas the molars were the least affected. Exposure to cold air and sweet foods, gingival recession, and the presence of noncarious cervical lesions were all strongly linked to DH (Logistic regression analysis, p < 0.05). The cold stimulus increases sensitivity more than the evaporation stimulus. Significant risk factors for both thermal and evaporative DH include cold air, consumption of sweet food, presence of noncarious cervical lesions, and gingival recession. More epidemiological research in this area is still required to fully characterize the risk factors and implement the most effective preventive interventions.

Identifiants

pubmed: 37434150
doi: 10.1186/s12903-023-03137-1
pii: 10.1186/s12903-023-03137-1
pmc: PMC10334656
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

474

Informations de copyright

© 2023. The Author(s).

Références

Aust Dent J. 2009 Mar;54(1):2-8
pubmed: 19228125
Eur Rev Med Pharmacol Sci. 2012 Aug;16(8):1107-16
pubmed: 22913162
Br Dent J. 1987 Apr 11;162(7):253-6
pubmed: 3472555
J Clin Periodontol. 1997 Nov;24(11):808-13
pubmed: 9402502
Int J Dent Hyg. 2017 Nov;15(4):e69-e77
pubmed: 26842382
J Dent. 2018 Apr;71:1-8
pubmed: 29262305
Int Dent J. 2016 Feb;66(1):49-57
pubmed: 26582076
Clin Oral Investig. 2013 Mar;17 Suppl 1:S9-19
pubmed: 23224116
Int J Dent Hyg. 2010 May;8(2):95-100
pubmed: 20522131
Int Dent J. 1972 Jun;22(2):219-27
pubmed: 4505631
J Oral Rehabil. 2012 Nov;39(11):812-20
pubmed: 22882603
J Int Oral Health. 2013 Oct;5(5):15-9
pubmed: 24324299
BMC Oral Health. 2020 Aug 26;20(1):234
pubmed: 32843000
Acta Odontol Scand. 2017 Aug;75(6):387-393
pubmed: 28502198
J Dent. 2013 Jul;41 Suppl 4:S49-55
pubmed: 23929645
J Dent. 2019 Feb;81:1-6
pubmed: 30639724
BMC Oral Health. 2014 Jun 05;14:65
pubmed: 24902953
Niger J Clin Pract. 2012 Oct-Dec;15(4):415-9
pubmed: 23238190
Clin Oral Investig. 2022 Mar;26(3):2719-2732
pubmed: 35083586
Clin Oral Investig. 2014;18(2):651-7
pubmed: 23740320
J Periodontol. 1967 Nov-Dec;38(6):Suppl:610-6
pubmed: 5237684
J Dent. 2018 Sep;76:58-67
pubmed: 29933005
J Oral Rehabil. 2020 Apr;47(4):473-479
pubmed: 31860124
J Oral Rehabil. 2012 Mar;39(3):182-7
pubmed: 21902706
J Oral Rehabil. 2011 Jan;38(1):52-60
pubmed: 20722772
J Oral Rehabil. 2014 Apr;41(4):289-95
pubmed: 24484047
J Clin Periodontol. 2002 Nov;29(11):997-1003
pubmed: 12472992
J Clin Periodontol. 1997 Apr;24(4):209-15
pubmed: 9144042
J Dent. 2013 Oct;41(10):841-51
pubmed: 23911597
Br Dent J. 1999 Dec 11;187(11):606-11; discussion 603
pubmed: 16163281
Clin Oral Investig. 2008 Mar;12 Suppl 1:S65-8
pubmed: 18228057
J Dent. 1992 Oct;20(5):272-6
pubmed: 1452864
J Pain. 2003 Sep;4(7):407-14
pubmed: 14622683
J Dent. 1985 Sep;13(3):230-6
pubmed: 3862690
J Dent. 2017 Dec;67:84-87
pubmed: 29017845
J Indian Soc Periodontol. 2014 Sep;18(5):549-54
pubmed: 25425813
J Periodontol. 2014 Sep;85(9):1247-58
pubmed: 24527854
Aust Dent J. 2006 Sep;51(3):212-8; quiz 276
pubmed: 17037886
J Oral Rehabil. 2013 Dec;40(12):948-57
pubmed: 24180256
J Clin Periodontol. 2010 Jul;37(7):631-7
pubmed: 20041975
J Oral Rehabil. 2016 Dec;43(12):960-966
pubmed: 27658541
J Periodontol. 2013 Mar;84(3):295-306
pubmed: 22548583
J Dent. 2015 Feb;43(2):248-52
pubmed: 25449958
Clin Oral Investig. 2013 Mar;17 Suppl 1:S3-8
pubmed: 23224064
J Dent. 2018 Aug;75:12-21
pubmed: 29787782
J Periodontol. 2006 Mar;77(3):454-9
pubmed: 16512760
J Clin Periodontol. 2019 Apr;46(4):448-456
pubmed: 30825378
J Oral Rehabil. 1999 Sep;26(9):710-4
pubmed: 10520145
J Clin Diagn Res. 2014 Sep;8(9):ZC48-51
pubmed: 25386522
J Periodontol. 2013 Mar;84(3):287-94
pubmed: 22524329
Monogr Oral Sci. 2014;25:108-22
pubmed: 24993261
J Can Dent Assoc. 2003 Apr;69(4):221-6
pubmed: 12662460
Int Dent J. 2009 Dec;59(6):376-80
pubmed: 20162951
Acta Odontol Latinoam. 2019 Dec 1;32(3):156-163
pubmed: 32176239
J Dent. 2018 Sep;76:93-97
pubmed: 29940290
J Oral Rehabil. 1997 Sep;24(9):666-72
pubmed: 9357747
Niger Postgrad Med J. 2011 Sep;18(3):205-9
pubmed: 21980643
J Oral Rehabil. 2017 Feb;44(2):112-118
pubmed: 27973740
Dent Clin North Am. 1990 Jul;34(3):503-14
pubmed: 2197124
BMC Oral Health. 2018 Sep 3;18(1):155
pubmed: 30176855
J Clin Dent. 1994;5 Spec No:87-92
pubmed: 8534380
Acta Odontol Scand. 2019 Apr;77(3):219-223
pubmed: 30646808

Auteurs

Gunseli Katirci (G)

Department of Restorative Dentistry, Faculty of Dentistry, Suleyman Demirel University, Isparta, Turkey. gunselikatirci@sdu.edu.tr.

Esra Uzer Celik (EU)

Department of Restorative Dentistry, Faculty of Dentistry, İzmir Katip Celebi University, Izmir, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH